v3.26.1
Equity Plans (Tables)
6 Months Ended
Feb. 27, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Aggregate Restricted Award Activity and Assumptions
Restricted Award activity was as follows:
Three Months EndedSix Months Ended
February 27,
2026
February 28,
2025
February 27,
2026
February 28,
2025
Restricted awards granted839602,339683
Weighted-average grant date fair value per share$19.76 $20.59 $20.85 $20.79 
Aggregate vesting date fair value of shares vested$8,255 $10,649 $21,619 $19,677 
Schedule of Share Based Compensation Expense Allocation
Stock-based compensation expense for our continuing operations was as follows:
Three Months EndedSix Months Ended
February 27,
2026
February 28,
2025
February 27,
2026
February 28,
2025
Stock-based compensation expense by caption:
Cost of sales$1,522 $1,776 $2,908 $3,419 
Research and development1,636 1,598 3,130 3,287 
Selling, general and administrative1,961 8,206 9,161 16,405 
 $5,119 $11,580 $15,199 $23,111